TB Alternative Assets’s Moderna MRNA Stock Holding History

TB Alternative Assets’s Portfolio MRNA Stock Details MRNA Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q2	$609K	Buy	+8,700	New	+$450K	0.1%	29
2025 Q4	–	Sell	-658,881	Closed	-$17M	–	57
2025 Q3	$17M	Sell	658,881 -602,072	-48%	-$16.8M	2.55%	14
2025 Q2	$34.8M	Buy	1,260,953 +608,580	+93%	+$16M	6.44%	8
2025 Q1	$18.5M	Buy	+652,373	New	+$23.2M	4.3%	10
2024 Q2	–	Sell	-59,900	Closed	-$6.38M	–	42
2024 Q1	$6.38M	Buy	+59,900	New	+$6.04M	1.6%	19

Other funds holding MRNA

BPC

Banque Pictet & Cie Geneva 73, Switzerland $16B AUM 29.1% 1-Year Est. Return

DLA

Douglas Lane & Associates New York $7.37B AUM 21.9% 1-Year Est. Return

OIAM

OFI Invest Asset Management Paris, France $10B AUM 48.47% 1-Year Est. Return

LSA

Leonteq Securities AG Zurich, Switzerland $2.91B AUM 56.5% 1-Year Est. Return

New York State Teachers Retirement System (NYSTRS) Albany, New York $54.2B AUM 43.77% 1-Year Est. Return

TFCP

Twin Focus Capital Partners Boston, Massachusetts $983M AUM 37.07% 1-Year Est. Return

YIH

Y-Intercept (HK) Hong Kong $5.05B AUM 17.89% 1-Year Est. Return

Handelsbanken Fonder Stockholm, Sweden $35.1B AUM 47.76% 1-Year Est. Return

CNB

Czech National Bank Prague, Czech Republic $18.3B AUM 43.04% 1-Year Est. Return

Mirae Asset Global Investments Seoul, South Korea $67.7B AUM 51.91% 1-Year Est. Return

TB Alternative Assets's MRNA Position: Q2 2026 in Review

TB Alternative Assets opened a new position in Moderna (MRNA) in Q2 2026: 8,700 shares worth $609K. The stake represents 0.1% of the portfolio and ranks #29 among its holdings. This is a return to the name: TB Alternative Assets previously reported a position in MRNA as recently as Q3 2025.

TB Alternative Assets first reported a position in MRNA in Q1 2024 and has held it in 5 quarters since. The position peaked at $34.8M in Q2 2025. 225 funds tracked by Wall St. Rank hold MRNA as of Q2 2026.

TB Alternative Assets held 8,700 shares of Moderna worth $609K as of Q2 2026.
Moderna was a new TB Alternative Assets position in Q2 2026.
Moderna made up 0.1% of TB Alternative Assets's portfolio in Q2 2026, its #29 holding.
TB Alternative Assets first reported a position in Moderna in Q1 2024 and has held it in 5 quarters since.
TB Alternative Assets's Moderna position peaked at $34.8M in Q2 2025.
225 funds tracked by Wall St. Rank held Moderna as of Q2 2026.

Based on TB Alternative Assets's 13F filing for Q2 2026, filed 17 Jul 2026.